Neonatal candidiasis: Analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 10, 2004, Pages 745-750

  Roilides, E ^a   Farmaki, E ^a   Evdoridou, J ^a   Dotis, J ^a   Hatziioannidis, E ^a   Tsivitanidou, M ^b   Bibashi, E ^b   Filioti, I ^a   Sofianou, D ^b   Gil Lamaignere, C ^c   Mueller, F M ^c   Kremenopoulos, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS ISOLATION; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PERITONITIS; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ARTHRITIS, INFECTIOUS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGEMIA; GREECE; HUMANS; INCIDENCE; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; MENINGITIS, FUNGAL; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 8744283559     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1210-9     Document Type: Article

References (48)

1. Leibovitz E (2002) Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options. J Antimicrob Chemother 49(Suppl 1):69-73
2. Chapman RL (2003) Candida infections in the neonate. Curr Opin Pediatr 15:97-102
3. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JE, Jarvis W, Dawson J, Wenzel RP (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253-258
4. Lopez Sastre JB, Coto Collado GD, Colomer BF, Grupo de Hospitales Castrillo (2003) Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 20:153-163
5. da Silva CL, dos Santos RM, Colombo AL (2001) Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit. Braz J Infect Dis 5:32-36
6. Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY (1999) Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 27:97-102
7. Lupetti A, Tavanti A, Davini P, Ghelardi E, Corsini V, Merusi I, Boldrini A, Campa M, Senesi S (2002) Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 40:2363-2369
8. Singh N (2001) Changing spectrum of invasive candidiasis and its therapeutic implications. Clin Microbiol Infect 7:1-7
9. Krcmery V, Barnes AJ (2002) Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50:243-260
10. Rowen JL, Tate JM, Nordoff N, Passarell L, McGinnis MR (1999) Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol 37:3735-3737
11. Huang YC, Lin RI, Chou YH, Kuo CY, Yang PH, Hsieh WS (2000) Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. J Infect 40:171
12. Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ (2003) Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41:735-741
13. Welbel SF, McNeil MM, Kuykendall RJ, Lott TJ, Pramanik A, Silberman R, Oberle AD, Bland LA, Aguero S, Arduino M, Crow S, Jarvis WR (1996) Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 15:998-1002
14. National Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. NCCLS, Villanova
15. Müller FMC, Lischewski A, Harmsen D, Hacker J (1999) Standardized molecular typing. Mycoses 42(Suppl 2):69-72
16. Gil-Lamaignere C, Roilides E, Hacker J, Müller FMC (2003) Molecular typing for fungi - a critical review of the possibilities and limitations of the currently in use and future methods. Clin Microbiol Infect 9:172-185
17. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32:1115-1118
18. Lasker BA, Page LS, Lott TJ, Kobayashi GS (1992) Isolation, characterization and sequencing of Candida albicans repetitive element 2. Gene 116:51-57
19. Müller FMC, Kasai M, Francesconi A, Brillante B, Roden M, Peter J, Chanock SJ, Walsh TJ (1999) Transmission of an azole-resistant isogenic strain of Candida albicans among HIV-infected family members with oropharyngeal candidiasis. J Clin Microbiol 37:3405-3408
20. Ruhnke M, Adler A, Müller FM (2000) Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection. Clin Microbiol Infect 6:220-223
21. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
22. Kossoff EH, Buescher ES, Karlowicz MG (1998) Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17:504-508
23. Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH (2003) Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112:543-547
24. Levy I, Rubin LG, Vasistha S, Tucci V, Sood SK (1998) Emergence of Candida parapsilosis as the predominant species causing candidaemia in children. Clin Infect Dis 26:1086
25. Saxen H, Virtanen M, Carlson P, Hoppu K, Pohjavuori M, Vaara M, Vuopio-Varkila J, Peltola H (1995) Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J 14:776-781
26. Juster-Reicher A, Flidel-Rimon O, Amitay M, Even-Tov S, Shinwell E, Leibovitz E (2003) High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Eur J Clin Microbiol Infect Dis 22:603-607
27. Weems JJ, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL (1987) Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 25:1029-1032
28. Faix RG (1992) Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 11:88-93
29. Pandit PB, Pandit FA, Govan J, O'Brien K (1999) Complications associated with surgically placed central venous catheters in low birth weight neonates. J Perinatol 19:106-109
30. Girmenia C, Martino P, De Bernardis F, Gentile G, Boccanera M, Monaco M, Antonucci A (1996) Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 23:506-514
31. Flynn PM, Marina NM, Rivera GK, Hughes WT (1993) Candida tropicalis infections in children with leukemia. Leuk Lymphoma 10:369-376
32. Leung AY, Chim CS, Ho PL, Cheng VC, Yuen KY, Lie AK, Au WY, Liang R, Kwong YL (2002) Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect 50:316-319
33. Chowdhary A, Becker K, Fegeler W, Gugnani HC, Kapoor L, Randhawa VS, Mehta G (2003) An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses 46:287-292
34. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 24:235-247
35. Stamos JK, Rowley AH (1995) Candidemia in a pediatric population. Clin Infect Dis 20:571-575
36. Huang YC, Kao HT, Lin TY, Kuo AJ (2001) Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia. Am J Perinatol 18:141-146
37. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345:1660-1666
38. Filioti J, Pavlidou E, Farmaki E, Evdoridou J, Panagopoulou P, Tsivitanidou M, Kremenopoulos G, Roilides E (2002) Antifungal drug susceptibility of Candida spp. in a neonatal intensive care unit. Clin Microbiol Infect 8 (Suppl 1):100a
39. Kingo AR, Smyth JA, Waisman D (1997) Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J 16:1002-1003
40. Roilides E, Kadiltsoglou I, Zahides D, Bibashi E (1997) Invasive candidiasis in pediatric patients: a prospective study. Clin Microbiol Infect 3:192-197
41. Rowen JL, Tate JM (1998) Management of neonatal candidiasis. Neonatal Candidiasis Study Group. Pediatr Infect Dis J 17:1007-1011
42. Linder N, Klinger G, Shalit I, Levy I, Ashkenazi S, Haski G, Levit O, Sirota L (2003) Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother 52:663-667
43. Weems JJ (1992) Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 14:756-766
44. Arendrup M, Horn T, Frimodt-Moller N (2002) In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30:286-291
45. Bistoni F, Vecchiarelli A, Cenci E, Sbaraglia G, Perito S, Cassone A (1984) A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. Sabouraudia 22:409-418
46. Waggoner-Fountain LA, Whit Walker M, Hollis RJ, Pfaller MA, Ferguson JE, Wenzel RP, Donowitz LG (1996) Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis 22:803-808
47. Huang Y, Lin T, Peng H, Wu J, Chang H, Leu H (1998) Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis 30:137-142
48. Faix RG, Finkel DJ, Andersen RD, Hostetter MK (1995) Genotypic analysis of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. Pediatr Infect Dis J 14:1063-1068